Clinical trials
Phase 1 Leukemia, B-Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
| Completed | 1 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| iCell Gene Therapeutics | 2 |
| Chinese PLA General Hospital | 1 |
| Hebei Yanda Ludaopei Hospital | 1 |
| Henan Cancer Hospital | 1 |
| Immune Cell, Inc. | 1 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 1 |
| The First Affiliated Hospital of Soochow University | 1 |
| The First People's Hospital of Yunnan | 1 |
| Wondercel Biotech (ShenZhen) | 1 |
| Xin Wang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 12 |
| Lymphoma, B-Cell | 6 |
| Recurrence | 3 |
| Leukemia | 2 |
| Lymphoma | 2 |
| Burkitt Lymphoma | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.